465 related articles for article (PubMed ID: 33309846)
1. Understanding the role of colon-specific microparticles based on retrograded starch/pectin in the delivery of chitosan nanoparticles along the gastrointestinal tract.
Dos Santos AM; Meneguin AB; Akhter DT; Fletcher N; Houston ZH; Bell C; Thurecht KJ; Gremião MPD
Eur J Pharm Biopharm; 2021 Jan; 158():371-378. PubMed ID: 33309846
[TBL] [Abstract][Full Text] [Related]
2. The in vivo fate of nanoparticles and nanoparticle-loaded microcapsules after oral administration in mice: Evaluation of their potential for colon-specific delivery.
Ma Y; Fuchs AV; Boase NR; Rolfe BE; Coombes AG; Thurecht KJ
Eur J Pharm Biopharm; 2015 Aug; 94():393-403. PubMed ID: 26117186
[TBL] [Abstract][Full Text] [Related]
3. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
[No Abstract] [Full Text] [Related]
4. Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles.
Liu L; Yang H; Lou Y; Wu JY; Miao J; Lu XY; Gao JQ
Int J Pharm; 2019 Feb; 557():170-177. PubMed ID: 30597264
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of 5-fluorouracil and shikonin by blended and coated chitosan/pectin nanoparticles for treatment of colon cancer.
Daneshmehr M; Pazhang M; Mollaei S; Ebadi M; Pazhang Y
Int J Biol Macromol; 2024 Jun; 270(Pt 2):132413. PubMed ID: 38761911
[TBL] [Abstract][Full Text] [Related]
6. Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation.
Guo F; Zhang M; Gao Y; Zhu S; Chen S; Liu W; Zhong H; Liu J
Drug Deliv; 2016 Jul; 23(6):2003-14. PubMed ID: 26181840
[TBL] [Abstract][Full Text] [Related]
7. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
8. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X
Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170
[TBL] [Abstract][Full Text] [Related]
9. Entrapping of Nanoparticles in Yeast Cell Wall Microparticles for Macrophage-Targeted Oral Delivery of Cabazitaxel.
Ren T; Gou J; Sun W; Tao X; Tan X; Wang P; Zhang Y; He H; Yin T; Tang X
Mol Pharm; 2018 Jul; 15(7):2870-2882. PubMed ID: 29863879
[TBL] [Abstract][Full Text] [Related]
10. Statistical simplex centroid experimental design for evaluation of pectin, modified chitosan and modified starch as encapsulating agents on the development of vitamin E-loaded microparticles by spray-drying.
Ribeiro AM; Gonçalves A; Rocha F; Estevinho BN
Int J Biol Macromol; 2024 Jun; 269(Pt 1):131792. PubMed ID: 38677704
[TBL] [Abstract][Full Text] [Related]
11. Retrograded starch/pectin coated gellan gum-microparticles for oral administration of insulin: A technological platform for protection against enzymatic degradation and improvement of intestinal permeability.
Meneguin AB; Beyssac E; Garrait G; Hsein H; Cury BSF
Eur J Pharm Biopharm; 2018 Feb; 123():84-94. PubMed ID: 29175551
[TBL] [Abstract][Full Text] [Related]
12. Taurine loaded chitosan-pectin nanoparticle shows curative effect against acetic acid-induced colitis in rats.
Ahmed O; Abdel-Halim M; Farid A; Elamir A
Chem Biol Interact; 2022 Jan; 351():109715. PubMed ID: 34695389
[TBL] [Abstract][Full Text] [Related]
13. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
14. Development and in vitro/in vivo evaluation of Zn-pectinate microparticles reinforced with chitosan for the colonic delivery of progesterone.
Gadalla HH; Soliman GM; Mohammed FA; El-Sayed AM
Drug Deliv; 2016 Sep; 23(7):2541-2554. PubMed ID: 25853478
[TBL] [Abstract][Full Text] [Related]
15. Alginate/chitosan microparticles for gastric passage and intestinal release of therapeutic protein nanoparticles.
Ling K; Wu H; Neish AS; Champion JA
J Control Release; 2019 Feb; 295():174-186. PubMed ID: 30557649
[TBL] [Abstract][Full Text] [Related]
16. Cyclodextrin nanoparticle bound oral camptothecin for colorectal cancer: Formulation development and optimization.
Ünal S; Aktaş Y; Benito JM; Bilensoy E
Int J Pharm; 2020 Jun; 584():119468. PubMed ID: 32470483
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and anti-colon cancer properties of curcumin-containing chitosan-pectinate composite nanoparticles.
Alkhader E; Roberts CJ; Rosli R; Yuen KH; Seow EK; Lee YZ; Billa N
J Biomater Sci Polym Ed; 2018 Dec; 29(18):2281-2298. PubMed ID: 30376409
[TBL] [Abstract][Full Text] [Related]
18. A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity.
Deng L; Dong H; Dong A; Zhang J
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):107-17. PubMed ID: 26515259
[TBL] [Abstract][Full Text] [Related]
19. Electrostatic Self-Assembled Chitosan-Pectin Nano- and Microparticles for Insulin Delivery.
Maciel VBV; Yoshida CMP; Pereira SMSS; Goycoolea FM; Franco TT
Molecules; 2017 Oct; 22(10):. PubMed ID: 29023400
[TBL] [Abstract][Full Text] [Related]
20. An oral drug delivery system with programmed drug release and imaging properties for orthotopic colon cancer therapy.
Song Q; Jia J; Niu X; Zheng C; Zhao H; Sun L; Zhang H; Wang L; Zhang Z; Zhang Y
Nanoscale; 2019 Aug; 11(34):15958-15970. PubMed ID: 31418432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
